secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2022-08-17T23:59:59+00:00
Accession:  0001193125-22-222443
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulcrum Therapeutics announces $75M public offering of common stock at $7.82/share
--------------------------------------------------------------------------------

- 9,590,792 shares offered at $7.82/share; gross proceeds $75 million.
- Net proceeds estimated at $70.3 million ($80.9 million if underwriters exercise full 30-day option for 1,438,618 additional shares).
- Goldman Sachs & Co. and SVB Securities act as lead joint book-running managers; closing expected on August 18, 2022.
- Company subject to 60-day lock-up; directors and executive officers subject to 30-day lock-up.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312522222443/0001193125-22-222443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312522222443/d284968d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-222443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer